Outcome of Board Meeting

Health August 6, 2026 To, To, The Corporate Relations Department The Listing Department The BSE Limited The National Stock Exchange of India Limited Department of Corporate Services Exchange Plaza, Plot No. C/1, G Block, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400001. Mumbai – 400051 Ref:- Scrip Code:- 500126 Ref:- Symbol:- PGHL Dear Sir / Madam, Sub: Unaudited Financial Results for the quarter ended June 30, 2026 We are pleased to inform you that at the meeting of the Board of Directors of the Company held today (commenced at 1:26 P.M. (IST) and ended at 1:43 P.M.), the Unaudited Financial Results for the quarter ended June 30, 2026 were approved. We are enclosing herewith the following: a. Unaudited Financial Results for the quarter ended June 30, 2026; b. Limited Review Report, in respect of the Unaudited Financial Results for the quarter ended June 30, 2026, as furnished by the Statutory Auditors of the Company; Kindly take the same on record. Thanking you. For Procter & Gamble Health Limited Flavia Machado Authorized Signatory Procter & Gamble Health Limited C I\ l3~t:J99f.lH 9G7PLC01372G r:>e~J 1~l<;-ft'd 0111c. "'· (jrnL, nd f-CJ'-'' .mo F rsl F ,.,.:,r. P .• c p ,,d 11,,I GI.I( Ru.I(! Anoncrd 1. " E.l ., ( t" ,l .;m1JJ1 ..o o 0d 9', 9 Tc- C (-:3h 1. 1 2k 2.1 ) I GI SGG 90:::>0 .•:·,,, "'· .pqllE-.i I ll111101,1.,.orn HARIBHAKTI & CO. LLP Independent Auditor's Review Report on quarterly Unaudited Financial Results of Procter & Gamble Health Limited pursuant to the Regulation 33 of SEBI (Listing Obligations and Disclosures Requirements) Regulations. 2015 (as amended) To the Board of Directors Procter & Gamble Health Limited 1. We have reviewed the accompanying Statement of Unaudited Financial Results of Procter & Gamble Health Limited ("the Company") for the quarter ended June 30, 2026 ("the Statement"), being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('Listing Regulations'). 2. This Statement, which is the responsibility of the Company's Management and approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 "Interim Financial Reporting" prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder (hereinafter referred to as "the said Indian Accounting Standard") and other accounting principles generally accepted in India. Our responsibility is to issue a report on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review is limited primarily to inquiries of the company personnel and analytical procedures applied to financial data and thus provide less assurance than ari. audit. We have not performed an audit and accordingly, we do not express an audit opinion. I. :.:.<o Haribhakti & Co. LLP, Chartered Accountants (LLPIN: AAC-3768) Registered office: 904A, 9th Floor, R Square, Andheri-Kurla Road, Near Chakala Metro Station, J. B. Nagar; Mumbai-400059. www.haribhakti.co.in I info@haribhakti.co.in I Tel: +91 22 6672 9998 Other offices: Ahmedabad, Bengaluru, Chennai, Kolkata, New Delhi, Pune, Rajkot, Vadodara. HARIBHAKTI & CO. LLP 4. Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention . that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the said Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. For Haribhakti & Co. LLP Chartered Accountants ICAI Firm Registration No.103523W /W100048 Partner ~ p No.: 034828 UDIN: 26034828ZDFPLL6389 Place: Mumbai Date: August 06, 2026 Continuation Sheet PROCTER & GAMBLE HEALTH LIMITED Regd. Offict1: P&G Plata, Cardinal Grae.In Road, Chall.ala. Andher1 {E), Mumbai: 400 099. ON No. l99999MH1967PLC013726, email: lnvestc.grievan~.im@IP1,C.cm STATEMENT OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 3DTH JUNE 2026 ('' in lakhs) (1) (2) {31 141 Three months Precedin1 Three Co.rnpondin1 Previous Vc-ar 5<. P.wticulars ended months l!!nded Three months tnded No. 30th Juno 2026 31st March 2026 ended 31st Mafdl 2026 30th Juna 2025 (Audited) (U111udltod) (Refer note 4 (Unaudlt•dl (Audited) bolow) 1. A:e¥1!!nue from Operations 3637] 37oq5 B874 140 797 Z, Other Income 388 400 403 1734 3, total Income (1+2) 36759 37445 34zn 142551 Expenses a) Cast of n,atenab <OMUrned 8031 8519 S 9S4 30133 b) Purchases. of stoc.k•in,-trade {Traded 1oocb,) 2 456 2 231 2431 7058 c) Chan1:t1s In Inventories of finished goods,work•iR'l>f"Oiress and s.toclc: ln trade I 865) (1463) 1 D14 (1283) d) £mplovee benefits. expenses 6039 5 086 5 601 22 256 e) Depredation and amortisation axpen:Hts 602 617 544 2359 O Finance costs 14 21 12 55 11 Other e,penses 10750 9113 9840 36367 4. Total expe:nses (4} 27027 24124 25396 97545 s. Protrt before exceptional ltams and tax (3-4J 9731 13321 11181 4498i Add; Ew.ceptioni.l Item (refer note 1') 3181) 7. Profit before ta. (5+6) 12912 13311 8111 44985 a. Ta-. expenses a) Cumrnt Tax 3103: 2808 2 294 11082 b] Oeferred Tax Charae / [Credit) 194 6!'>0 (.3 1) 446 c)Adiu,:tment of tu: relating to urlfer periods 4<)) 767 Total tax eq,enses 3297 3861 2263 12295 Net PJOfit tor tho period / v••r (7-ll) '515 ,,r;o '618 n,n 10. othertompcel'la1sfve tncome Items. thit wHI nat be rttdasslfied to profit or toss I. Re-rne:nurem1?1\t satt,s I (tosses.) oi, defined be"efit ph,ns 41 I 392) I s1) I 38) Ii.Income tn r:ffect on above 1101 99 22 10 Othe:r Cornpr1-h1-nsive lncorv, net of tax 31 I 2931 f65 f 28 11. Total Comprehensive huame for the period/ year 1!+10) H46 9 167 &SU 32663 12. Paid-up •~ulty share apltal (Face Value~ 10/· Heh) 1660 1660 1660 1660 ll. Other 11quity 50795 14. rarnlop per equity share (of~ 10/· 11ch) •(not1..,.,1llsed) l•l Bask aod D~uted (io ~l (before •,.optional Jlems) • 38.77 • 56,99 •39.97 1.!16.94 (b) 8asic and Diluted lin ~) (after o,ceptlonal l••ms) • 57.92 • 56,99 • 39.87 1.!16.94 PROCTER & GAMBLE HEALTH LIMITED Regd. Office: P&G Plaza, Cardinal Gc-acla.s Road, Chakalai, Andherl (E}, Mumbai; -400 099. CIN No. L99999MH1967PLC013726, emaJI: investargrievance.im@PR-COm Notes: 1 The above Unaudited fjnancia1 Ri!!-su~ts have lw,,en revil!',wed by the Audit Committee and .i!pproved by the Board of Directors of the Company at their respective meetm1:s held on Augus. 6, 2026 and have been subjected to a limited review by 1he Statutory Auditor.; of the Comp~ny.The,:,;e finilnr:ial re~ults are prepared and published In accordance with Regulation 33 of th SEBI (listing Obligation'!i and Di:§d05ure Requitem1mt:i.) Regulations, 2015, as .i!mended and exp.re!ised nunmodified" condu,.ion 2. This Statement has been prepared in .accordance with the Companies ("rndlan Accounting Standards") Rules~ 2015 ("IND AS") prescribed ut\dct Section 133 of the Companie:§. Art, 2013 and other recognised accounting practices and policies to the extent applicable 3. The Company does not have a subsidiary, an associate or a joint venture as at 30 June, 2026. 4. The ftg-ures foe the p.receeding three months ended March 31, 1026, a,re the balancing f~uces between the audited figufe"i in resp,ect of the year ended March 31, 2026 and the pubhsh unaudi [Showing first 8,000 characters — download PDF for full document]